Filing Flows › Teva Pharmaceutical Industries (TEVA) › Q3 2026
Teva Pharmaceutical Industries (TEVA) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 3, 2026
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.4B for the third quarter 2026 (Q3 2026), -2% from a year earlier and +6% from the quarter before. Operating margin was 16.2%, net earnings $234M (5.3% of revenue).
Teva Pharmaceutical Industries, Q3 2026: revenue $4.4B (-2% year over year), operating margin 16.2%, net earnings $234M, operating cash flow $241M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.4B | +6% | -2% |
| Gross profit | $2.4B | +13% | +6% |
| Operating profit | $714M | — | -19% |
| Net earnings | $234M | — | -46% |
| Operating cash flow | $241M | -41% | -35% |
| Free cash flow | $121M | -61% | -48% |
What changed
Revenue was $4.4B in Q3 2026, down 2% year over year and up 6% from the previous quarter. Sale of goods was the largest line at 85% of revenue. Sale of goods lost $0.17B year over year (down 4%), 196% of the total change.
Gross margin was 55.5%, up 4.1 points from Q3 2025. Operating profit was $0.71B, a 16.2% margin (down 3.4 points year over year). Operating expenses grew 21% against a revenue fall of 2%. The fastest-growing cost line was Other operating costs (+119%). Net earnings were $0.23B, down 46% year over year. The effective tax rate was 22.0%.
Operating cash flow was $0.24B (down 35% year over year), 103% of net earnings. Non-cash charges added back $0.24B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items used $0.28B. Capital expenditures of $0.12B left free cash flow of $0.12B.
Questions
What was Teva Pharmaceutical Industries' revenue in the third quarter 2026?
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.4B for the third quarter 2026 (Q3 2026), -2% from a year earlier and +6% from the quarter before.
Was Teva Pharmaceutical Industries profitable in the third quarter 2026?
Operating profit was $714M (16.2% of revenue) and net earnings $234M.